Project Grant R34CA313437
Award Date 7/1/26
Completion Date 6/30/29
Dollars Obligated $310K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10016, USA
Similar Awards
- Grant Award Summary Duke University received a $906,306 Project Grant from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) awarded September 11, 2025, with completion targeted for August 31, 2028. The award funds development and testing of a telehealth-delivered, cue-based treatment intervention designed to promote smoking cessation among people who smoke lightly (PSLI), defined as those smoking 10 cigarettes per day or fewer. Building...
- Federal Grant Award Summary The National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), awarded the University of Alabama a Project Grant of $2,524,071 on September 23, 2025, for research investigating the neurocomputational mechanisms underlying self-regulation and reinforcement learning in smoking cessation decisions. The four-year project, with completion scheduled for August 31, 2029, will employ computational model-based multimodal neuroimaging...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded the University of Pennsylvania a Project Grant of $663,554 under the Cancer Cause and Prevention Research program (CFDA 93.393) on August 18, 2025, with an ultimate completion date of July 31, 2030. This research project, titled "Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit," will develop and test harm reduction product sampling as a pragmatic...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded The Research Foundation for the State University of New York a $467,581 Project Grant (CFDA 93.393: Cancer Cause and Prevention Research) effective July 1, 2026, through June 30, 2028, to conduct research on the mechanisms of substance use behaviors among young adult cancer survivors. The research employs a mixed-methods ecological momentary assessment approach to identify socioecological drivers of substance use—including...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded the University of Pittsburgh a $2.2 million Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) on August 7, 2025, with a completion date of July 31, 2029. This basic experimental study with humans addresses smoking cessation and craving by investigating dyadic processes between romantic partners and smoking friends. The research integrates theoretical and methodological approaches from...
- Federal Project Grant Award Summary New York University received a $442,750 Project Grant award from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393), with performance extending from September 23, 2025 through August 31, 2027. This research initiative delivers a systematic, theory-driven analysis of implementation strategies for cervical cancer control policies in African low- and middle-income countries (LMICs). The project employs a rigorous...
- Federal Project Grant Summary The National Institute on Drug Abuse (NIDA) awarded The Trustees of Columbia University in the City of New York a $1.16 million Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a clinical trial of the Sense2Quit mobile health application for smoking cessation. The award, dated April 15, 2026, with a completion date of February 28, 2031, funds research specifically targeting people with HIV (PWH), a population with...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded Sloan-Kettering Institute for Cancer Research a $745,458 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) for the period July 1, 2026 through June 30, 2031. The award funds development and implementation of the PERSON Intervention, an innovative digital health solution designed to facilitate person-centered communication between oncology patients and clinicians. The intervention...
- Federal Project Grant Award Summary Albert Einstein College of Medicine received a $695,154 Project Grant from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), awarded July 1, 2026, with a completion date of June 30, 2031. The grant funds research investigating inter-individual phenotypes of cancer gene mutation susceptibility in the human airway. The project will employ single-molecule mutation sequencing (SMM-Seq) technology to assess...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded Virginia Polytechnic Institute & State University a $395,248 Project Grant effective August 11, 2025, under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct proof-of-concept and feasibility testing of episodic future thinking (EFT) interventions for smoking cessation. This two-year project, concluding July 31, 2027, will develop and evaluate both generalized EFT and cancer-specific EFT approaches...